JP2013532035A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013532035A5 JP2013532035A5 JP2013517408A JP2013517408A JP2013532035A5 JP 2013532035 A5 JP2013532035 A5 JP 2013532035A5 JP 2013517408 A JP2013517408 A JP 2013517408A JP 2013517408 A JP2013517408 A JP 2013517408A JP 2013532035 A5 JP2013532035 A5 JP 2013532035A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- irradiation device
- dry pharmaceutical
- pharmaceutically acceptable
- chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 229920001661 Chitosan Polymers 0.000 claims 8
- 229920000642 polymer Polymers 0.000 claims 7
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 claims 6
- 229960002749 aminolevulinic acid Drugs 0.000 claims 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 4
- 229920003086 cellulose ether Polymers 0.000 claims 4
- 238000004108 freeze drying Methods 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- 210000001215 vagina Anatomy 0.000 claims 3
- -1 5-ALA ester Chemical class 0.000 claims 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 2
- 229920002148 Gellan gum Polymers 0.000 claims 2
- 229920001218 Pullulan Polymers 0.000 claims 2
- 239000004373 Pullulan Substances 0.000 claims 2
- 229940072056 alginate Drugs 0.000 claims 2
- 235000010443 alginic acid Nutrition 0.000 claims 2
- 229920000615 alginic acid Polymers 0.000 claims 2
- 235000010418 carrageenan Nutrition 0.000 claims 2
- 239000000679 carrageenan Substances 0.000 claims 2
- 229920001525 carrageenan Polymers 0.000 claims 2
- 229940113118 carrageenan Drugs 0.000 claims 2
- 239000007888 film coating Substances 0.000 claims 2
- 238000009501 film coating Methods 0.000 claims 2
- 235000010492 gellan gum Nutrition 0.000 claims 2
- 239000000216 gellan gum Substances 0.000 claims 2
- 229920002674 hyaluronan Polymers 0.000 claims 2
- 229960003160 hyaluronic acid Drugs 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 235000019423 pullulan Nutrition 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 210000003679 cervix uteri Anatomy 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 238000003618 dip coating Methods 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 230000001678 irradiating effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000003232 mucoadhesive effect Effects 0.000 claims 1
- 230000035515 penetration Effects 0.000 claims 1
- 238000002428 photodynamic therapy Methods 0.000 claims 1
- 239000004014 plasticizer Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 238000000935 solvent evaporation Methods 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10251232 | 2010-07-09 | ||
| EP10251232.4 | 2010-07-09 | ||
| PCT/EP2011/061688 WO2012004399A1 (en) | 2010-07-09 | 2011-07-08 | Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013532035A JP2013532035A (ja) | 2013-08-15 |
| JP2013532035A5 true JP2013532035A5 (enExample) | 2014-08-21 |
| JP5991970B2 JP5991970B2 (ja) | 2016-09-14 |
Family
ID=44628087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013517408A Expired - Fee Related JP5991970B2 (ja) | 2010-07-09 | 2011-07-08 | 光力学的治療または光力学的診断で使用する乾燥組成物および当該乾燥組成物を含む装置 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130178787A1 (enExample) |
| EP (1) | EP2590714B1 (enExample) |
| JP (1) | JP5991970B2 (enExample) |
| KR (1) | KR101842732B1 (enExample) |
| AU (1) | AU2011275695B2 (enExample) |
| BR (1) | BR112013000613A2 (enExample) |
| CA (1) | CA2804337A1 (enExample) |
| ES (1) | ES2620780T3 (enExample) |
| WO (1) | WO2012004399A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140276107A1 (en) | 2011-10-14 | 2014-09-18 | Photocure Asa | Photodynamic diagnosis |
| CN102670577B (zh) * | 2012-05-18 | 2018-04-13 | 上海复旦张江生物医药股份有限公司 | 一种光敏剂组合物、其使用方法及用途 |
| US20140067024A1 (en) | 2012-08-30 | 2014-03-06 | Photocure Asa | Dual panel photodynamic therapy lamp |
| GB201221123D0 (en) | 2012-11-23 | 2013-01-09 | Photocure As | Device for photodynamic treatment |
| GB201306369D0 (en) | 2013-04-09 | 2013-05-22 | Photocure As | Irradiation device |
| WO2014204001A1 (ja) * | 2013-06-21 | 2014-12-24 | 国立大学法人 岡山大学 | 異常活性化細胞検出による悪性腫瘍の検査方法および異常活性化細胞除去環流返血治療装置 |
| GB201522398D0 (en) | 2015-12-18 | 2016-02-03 | Photocure As | Device for photodynamic therapy |
| US12194098B2 (en) * | 2017-06-21 | 2025-01-14 | Photocure Asa | Method for preparing a liquid pharmaceutical composition and device for use in such method |
| US20250188521A1 (en) | 2022-03-10 | 2025-06-12 | Singular Genomics Systems, Inc. | Nucleic acid delivery scaffolds |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4659096A (en) * | 1995-01-30 | 1996-08-21 | Angiomedics Ii Incorporated | Photolytic drug delivery systems |
| CZ291132B6 (cs) | 1995-03-10 | 2002-12-11 | Photocure Asa | Estery kyselin 5-aminolevulových a farmaceutický prostředek s jejich obsahem |
| GB2360459B (en) * | 2000-03-23 | 2002-08-07 | Photo Therapeutics Ltd | Therapeutic light source and method |
| US6551346B2 (en) * | 2000-05-17 | 2003-04-22 | Kent Crossley | Method and apparatus to prevent infections |
| GB0018528D0 (en) | 2000-07-27 | 2000-09-13 | Photocure Asa | Compounds |
| GB0018527D0 (en) | 2000-07-27 | 2000-09-13 | Photocure Asa | Composition |
| GB0118251D0 (en) | 2001-07-26 | 2001-09-19 | Photocure Asa | Method |
| US20030153590A1 (en) * | 2001-08-14 | 2003-08-14 | Oy Contral Pharma Ltd | Method of treating alcoholism or alcohol abuse |
| EP1312353A1 (en) | 2001-11-16 | 2003-05-21 | Ecole Polytechnique Federale De Lausanne (Epfl) | Method for hair removal |
| DE10202487A1 (de) * | 2002-01-23 | 2003-07-31 | Photonamic Gmbh & Co Kg | Dermales Applikationssystem für Aminolävulinsäure-Derivate |
| US20050085455A1 (en) * | 2003-10-16 | 2005-04-21 | Light Sciences Corporation | Photodynamic therapy for local adipocyte reduction |
| CA2457214A1 (en) * | 2004-02-06 | 2005-08-06 | Qlt Inc. | Photodynamic therapy for the treatment of acne |
| GB0406917D0 (en) | 2004-03-26 | 2004-04-28 | Photocure Asa | Compounds |
| GB0424833D0 (en) | 2004-11-10 | 2004-12-15 | Photocure Asa | Method |
| JP2008526418A (ja) | 2005-01-18 | 2008-07-24 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 放射線を放出するための電子制御されるカプセル |
| CA2602835A1 (en) * | 2005-03-31 | 2006-10-05 | Esther Mayer | Probe device, system and method for photobiomodulation of tissue lining a body cavity |
| US20070260231A1 (en) * | 2005-04-21 | 2007-11-08 | Ondine International, Ltd. | Optical probe for delivery of light |
| DE102006001736A1 (de) * | 2006-01-13 | 2007-07-26 | Margull, Matthias, Dipl.-Ing. | Vorrichtung zur Applikation von monochromatischem Licht in Körperöffnungen |
| GB0608315D0 (en) * | 2006-04-27 | 2006-06-07 | Univ St Andrews | Light emitting device for use in therapeutic and/or cosmetic treatment |
| US8292935B2 (en) * | 2006-09-12 | 2012-10-23 | Bistitec Pharma Marketing Ltd | Photonic device and method for treating cervical dysplasia |
| GB0724279D0 (en) * | 2007-12-12 | 2008-01-23 | Photocure Asa | Use |
| GB0816027D0 (en) * | 2008-09-03 | 2008-10-08 | Lumicure Ltd | Controlled light emitting apparatus |
| GB0823472D0 (en) | 2008-12-23 | 2009-01-28 | Photocure Asa | Product |
| GB0900461D0 (en) * | 2009-01-12 | 2009-02-11 | Photocure Asa | Photodynamic therapy device |
| CN102458388B (zh) | 2009-06-11 | 2016-09-28 | 光治疗Asa公司 | 半固体组合物及药物制品 |
-
2011
- 2011-07-08 BR BR112013000613A patent/BR112013000613A2/pt not_active IP Right Cessation
- 2011-07-08 ES ES11730030.1T patent/ES2620780T3/es active Active
- 2011-07-08 US US13/809,093 patent/US20130178787A1/en not_active Abandoned
- 2011-07-08 KR KR1020137002512A patent/KR101842732B1/ko not_active Expired - Fee Related
- 2011-07-08 JP JP2013517408A patent/JP5991970B2/ja not_active Expired - Fee Related
- 2011-07-08 AU AU2011275695A patent/AU2011275695B2/en not_active Ceased
- 2011-07-08 EP EP11730030.1A patent/EP2590714B1/en not_active Not-in-force
- 2011-07-08 WO PCT/EP2011/061688 patent/WO2012004399A1/en not_active Ceased
- 2011-07-08 CA CA2804337A patent/CA2804337A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013532035A5 (enExample) | ||
| CY1122516T1 (el) | Ετοιμες προς χρηση διατυπωσεις κετορολακης | |
| JP2009280627A5 (enExample) | ||
| JP5991970B2 (ja) | 光力学的治療または光力学的診断で使用する乾燥組成物および当該乾燥組成物を含む装置 | |
| WO2011139684A3 (en) | Nicotine-containing pharmaceutical compositions | |
| RU2016151163A (ru) | Композиции, включающие электрогидродинамически полученные волокна, для нанесения заданных доз активного вещества на кожу или слизистую оболочку | |
| JP2012025755A5 (enExample) | ||
| HRP20221355T1 (hr) | Liofilizirani pripravak citotoksičnih dipeptida | |
| WO2012079092A3 (en) | Testosterone undecanoate compositions | |
| GB201018289D0 (en) | Treatment of respiratory disorders | |
| RU2017112308A (ru) | Композиции и способы для лечения бессонницы | |
| PH12017500136A1 (en) | Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled textures, and uses thereof | |
| WO2012117257A8 (en) | Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer | |
| RU2013112807A (ru) | Композиция для доставки активных агентов в желудок | |
| EA032938B1 (ru) | Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения | |
| WO2020072601A1 (en) | Pharmaceutical compositions comprising otic therapeutic agents and related methods | |
| EA201190161A1 (ru) | Способ получения твердых лекарственных форм солифенацина и его фармацевтически приемлемых солей для перорального введения | |
| RU2011136636A (ru) | Фармацевтическая композиция для орального введения | |
| RU2014119858A (ru) | Применение мелатонина для лечения и/или предотвращения мукозита | |
| CN105209025A (zh) | 包括聚乙二醇类聚合物和/或乙烯基吡咯烷酮类聚合物作为分散稳定剂的含他达拉非游离碱的膜剂形式 | |
| RU2009137911A (ru) | Порошки для создания жирной лекарственной формы | |
| JP2013523740A5 (enExample) | ||
| RU2008147216A (ru) | Жидкая лекарственная композиция | |
| CY1121145T1 (el) | Συστημα χορηγησης φαρμακων για χορηγηση μιας υδατοδιαλυτης, κατιοντικης και αμφιφιλης φαρμακευτικως ενεργης ουσιας | |
| RU2015112586A (ru) | Фармацевтические композиции, содержащие флурбипрофен |